{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:21:25Z","timestamp":1713054085679},"reference-count":18,"publisher":"The Japan Geriatrics Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat","Jpn. j. geriat"],"published-print":{"date-parts":[[2024,1,25]]},"DOI":"10.3143\/geriatrics.61.41","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T22:12:56Z","timestamp":1712527976000},"page":"41-44","source":"Crossref","is-referenced-by-count":0,"title":["Blood biomarker of Lewy body disease","4\uff0e\u30ec\u30d3\u30fc\u5c0f\u4f53\u75c5\u306e\u8840\u6db2\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc"],"prefix":"10.3143","volume":"61","author":[{"given":"\u7d4c\u592a","family":"\u5e73\u8cc0","sequence":"first","affiliation":[{"name":"\u540d\u53e4\u5c4b\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7cfb\u7814\u7a76\u79d1\u795e\u7d4c\u5185\u79d1\u5b66"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u96c5\u592e","family":"\u52dd\u91ce","sequence":"additional","affiliation":[{"name":"\u540d\u53e4\u5c4b\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7cfb\u7814\u7a76\u79d1\u795e\u7d4c\u5185\u79d1\u5b66"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1704","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, et al.: Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 2017; 16: 55-65.","DOI":"10.1016\/S1474-4422(16)30291-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG: Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 2019; 90: 1234-1243.","DOI":"10.1136\/jnnp-2019-321111"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Vincent Dor\u00e9 V, et al.: High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease. Nature 2018; 554: 249-254.","DOI":"10.1038\/nature25456"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hansson O: Biomarkers for neurodegenerative diseases. Nat Med 2021; 27: 954-963.","DOI":"10.1038\/s41591-021-01382-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, M\u00fcller ML, et al.: Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review. Mov Disord 2015; 30: 928-935.","DOI":"10.1002\/mds.26191"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, et al.: Cognitive decline in Parkinson disease. Nat Rev Neurol 2017; 13: 217-231.","DOI":"10.1038\/nrneurol.2017.27"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mizutani Y, Ohdake R, Tatebe H, Higashi A, Shima S, Ueda A, et al.: Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease. J Neurol 2023; 270: 5461-5474.","DOI":"10.1007\/s00415-023-11875-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gonzalez MC, Ashton NJ, Gomes BF, Tovar-Rios DA, Blanc F, Karikari TK, et al.: Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies. JAMA Neurol 2022; 79: 32-37.","DOI":"10.1001\/jamaneurol.2021.4222"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ashton NJ, Janelidze S, Khleifat AAI, Leuzy A, van der Ende EL, Karikari TK, et al.: A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun 2021; 12: 3400.","DOI":"10.1038\/s41467-021-23620-z"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Buhmann C, Magnus T, Choe C-U: Blood neurofilament light chain in Parkinson's disease. J Neural Transm 2023; 130: 755-762.","DOI":"10.1007\/s00702-023-02632-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Boeve BF, Silber MH, Ferman TJ, Lin SC, Benarroch EE, Schmeichel AM, et al.: Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 2013; 14: 754-762.","DOI":"10.1016\/j.sleep.2012.10.015"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zhang X, Ma L, Liang D, Song B, Chen J, Huang Y, et al.: Neurofilament Light Protein Predicts Disease Progression in Idiopathic REM Sleep Behavior Disorder. J Parkinsons Dis 2023; 13: 485-499.","DOI":"10.3233\/JPD-223519"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, et al.: CSF and blood biomarkers for Parkinson's disease. Lancet Neurol 2019; 18: 573-586.","DOI":"10.1016\/S1474-4422(19)30024-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, et al.: Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 2008; 5: 55-59.","DOI":"10.1159\/000112832"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno S, Imamichi-Tatano Y, et al.: Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 2023; 29: 1448-1455.","DOI":"10.1038\/s41591-023-02358-9"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Kalia LV, Lang AE: Parkinson's disease. Lancet 2015; 386: 896-912.","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hattori M, Tsuboi T, Yokoi K, Tanaka Y, Sato M, Suzuki K, et al.: Subjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study. J Neurol 2020; 267: 1516-1526.","DOI":"10.1007\/s00415-020-09714-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hattori M, Hiraga K, Satake Y, Tsuboi T, Tamakoshi D, Sato M, et al.: Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis. NPJ Parkinson's Disease 2023; 9: 1-9.","DOI":"10.1038\/s41531-023-00507-y"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/61\/1\/61_61.41\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T04:27:55Z","timestamp":1712982475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/61\/1\/61_61.41\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.61.41","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"article-number":"61.41"}}